CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring ...

Eli Lilly & CSL seal a deal for clazakizumab partitions rights to maximize lifecycle value. CSL retains ESKD focus as Lilly prioritizes commercialization. CSL and Eli Lilly have struck a strategic ...

The most recent earnings report from CSL Limited (ASX:CSL) was disappointing for shareholders. Despite the soft profit numbers, our analysis has optimistic about the overall quality of the income ...

All hope might not be lost with this fallen angel. It's not hard to see why. CSL reported revenues of US$8.3 billion, a drop of 4% over the same period last year. Reported net profits after tax (NPAT) ...

Earnings call CSL reported H1 FY26 revenue of $8.3B (down 4% YoY, constant currency) and NPATA of $1.9B (down 7%). Reported NPAT fell 81% due to $1.05B in impairments. Despite challenges, full-year ...

CSL’s share slump following weak profits and a sudden CEO exit has pulled Australian healthcare stocks to multi-year lows, highlighting sector-wide concerns over regulation and investor sentiment. CSL ...

At five minutes past 4 o’clock on Tuesday afternoon, one of the country’s largest listed companies and an absolute ASX stalwart announced to the sharemarket that its chief executive had resigned. The ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...

CSL’s interim chief executive Gordon Naylor has pleaded with angry investors for more time to return the global healthcare giant to its former glory, saying he will look at selling or scaling back non ...

Battling lower vaccination rates in the US under the Trump administration’s public health policies and spiralling blood plasma sales in China, Mr Naylor faces a sceptical investment community fretting ...

CSL’s board has moved to hit the reset button just hours before a crucial earnings report. Late last night, CSL confirmed chief executive Paul McKenzie will retire, with long-time company executive ...